Life-Threatening Complications and Outcomes in XXXX with @entity1151 .

@entity1 @entity662 @entity99 @entity548 @entity28 @entity5 @entity1457 @entity26 @entity1163 @entity1151 @entity177 @entity5642 @entity1583 @entity1167 @entity204
BACKGROUND: Data are scarce about ICU @entity1 with @entity5 and severe @entity1151 . Here, our main objective was to identify risk factors for life-threatening complications, organ failures, and @entity204 in ICU @entity1 with severe @entity1151 , with special attention to the impact of @entity5 . We also described the clinical features of PE in @entity1 with and without @entity5 . METHODS: Data from consecutive adults admitted to our ICU in 2002-2011 with severe @entity1151 were collected retrospectively. Multivariate analysis was performed to look for factors associated with @entity204 , organ failures, or life-threatening complications ( @entity548 , recurrent PE, and @entity1167 ). RESULTS: Of 119 included @entity1 (42 [35%] with bilateral @entity1151 ), 41 had solid @entity5 , 27 @entity1583 , and 51 no @entity5 . The most common symptoms were @entity1163 (40%) and hemoptysis (18%) in @entity1 with solid and @entity1583 , respectively. Life-threatening complications occurred in 23 (19%) @entity1 ; risk factors were @entity28 (OR, 13.22; 1.93-90.70), disseminated @entity5642 / @entity99 (OR, 27.06; 5.14-142.46), fluid load >= 1000mL/24h (OR, 6.42; 1.60-25.76), and solid @entity5 (OR, 5.45; 1.15-25.89). Inhospital mortality was 27/119 (23%) and respiratory or @entity1457 developed in 36 (30%) @entity1 . Risk factors for these adverse outcomes were older age (OR, 1.04/year; 1.01-1.07), higher @entity26 flow rate (OR, 1.28/L; 1.13-1.45); and @entity177 (OR, 8.08; 2.50-26.11); whereas @entity662 was protective (OR, 0.13; 0.04-0.48). CONCLUSION: In this study, solid @entity5 was a risk factor for life-threatening complications but not for @entity204 .
